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| Summary |
Background. Diastrophic dysplasia is an osteochondrodysplasia 
belonging to the group of dysplasias caused by mutations in 
the diastrophic dysplasia sulfate transporter. This sindrome is 
a micromelic dysplasia with multiple bone deformities of the 
hands, feet, knees and spine.
Objective. Describe the first report of diastrophic displasia 
in Colombia 
Materials and methods. In this paper a Colombian adult 
patient with diastrophic dysplasia whose clinical diagnosis 
was confirmed at the molecular level is reported.
Results. In this first report of diastrophic dysplasia in Colombia 
we found that the patient was compound heterozygote for the 
already reported Arg279Trp substitution and an unpublished 
mutation, a Ser157Thr substitution in the SLC26A2 gene.
Conclusion. Bioinformatic analysis on the latter mutation 
suggested that it could correspond to a deleterious mutation 
because it is in a highly conserved domain of the sulfate 
transporter.
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Resumen
Antecedentes. La displasia diastrófica es una osteocondrodisplasia 
que pertenece al grupo de las enfermedades genéticas del 
esqueleto causadas por mutaciones en los transportadores 
de sulfato. Se presenta como una displasia micromélica con 
afectación de múltiples huesos y deformidades en manos, pies, 
rodillas y columna vertebral.
Objetivo. Describir el primer reporte de displasia diastrófica 
en Colombia.
Materiales y métodos. Se reporta un adulto colombiano con 
esta displasia, con confirmación clínica, radiológica y molecular.
Resultados. En este primer reporte colombiano, se encontró que 
la paciente presentó una mutación heterocigota compuesta, de 
Arg279Trp y Ser157Thr, esta última no reportada previamente, 
en el gen SLC26A2.
Conclusión. El análisis bioinformático de la mutación nueva 
sugiere que podría corresponder a una mutación deletérea 
dado que el dominio afectado en el transportador de sulfatos 
es altamente conservado.
Palabras clave: Activación Transcripcional, Colombia, 
Mutación, Osteocondrodisplasias. (DeCS).
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Introduction
Diastrophic dysplasia is an autosomal recessive 
osteochondrodysplasia described since 1960; at present, it 
belongs to Group 4 of the classification of genetic skeletal 
disorders (1). The term “diastrophic” was borrowed from geology 
by Lamy and Maroteaux (2), where diastrophism refers to the 
process of deformation of the earth´s crust where by geological 
structures are formed (3). 
This syndrome is a micromelic dysplasia with shortening 
of the limbs, normal sized head, mild shortening of the trunk, 
“hitchhiker” thumb that is caused by malformations in the 
first metacarpal, narrow chest, protruding abdomen, spinal 
deformities, contractures of large joints, dislocation of the radius, 
cleft palate (in 1/3 of cases) and external ear deformities. Other 
features include ulnar deviation of fingers, separation between 
the first and second toe, clubfoot and hemangiomas on the 
forehead (4) (5).
In 1994 Hästbacka et al. mapped by linkage analysis the 
gene causing diastrophic dysplasia, the SLC26A2, also known 
as DTDST (diastrophic dysplasia sulfate transporter), in the 
locus 5q32 (6). The gene encodes for a 739 amino acid protein 
with 12 transmembrane domains that acts as a sulfate carrier 
not dependent on sodium (7). This protein is a sulfate/chloride 
exchanger of the cell membrane; functional impairment lead 
to cellular depletion of sulfate and a consequent failure in the 
sulfation of cartilage proteoglycans (8).
The clinical spectrum of mutations in this gene is 
very heterogeneous, ranging from lethal forms as Type 2 
atelosteogenesis (AO2) and Type 1B Achondrogenesis (ACG1B) 
to nonlethal forms such as diastrophic dysplasia (DTD) and 
recessive multiple epiphyseal dysplasia (rMED), the latter being 
the mildest form of the disease (9). We present the first case 
reported in the national literature and perform a phenotypic and 
genotypic analysis of a 34 years old female patient with normal 
cognition. 
Case report
34 years old patient, the first offspring of nonconsanguineous 
Colombian parents. The mother reported that she had prenatal 
care during pregnancy without performing ultrasounds and thus 
without prenatal diagnosis. The birth was by c-section and no data 
were obtained from neonatal adaptation. The neonatal evaluation 
showed bilateral clubfoot and anomalies in the right outer ear. 
Psychomotor development with head support at 3 months, sitting 
at 8 months, crawled at 12 months and standing at 26 months; 
language development was adequate.
During childhood the patient started presenting various clinical 
problems, mostly related to orthopedic complications, but no 
hospitalization for respiratory events was required. At 2 years of 
age, she developed scoliosis, when she was 22 years old she was 
diagnosed with rupture of both menisci, recurrence of clubfoot 
which was refractory to surgery. Osteoarthritis of the hip was 
diagnosed at 31 years of age.
For the management of orthopedic complications she required 
several surgeries, including the correction of clubfoot 2 times at 
age 2 and 6, vertebral resection at age 3, right knee arthroscopic at 
age 26 and 27, right meniscus tear repair and excision of pilonidal 
cyst at age 21. The menarche occurred at age 14 and currently 
she has regular menstrual cycles (G0P0A0).
Her parents are not consanguineous; the only skeletal sign 
comes from the father who has ectrodactyly of left hand (Figure 1).
  Figure 1. Patient´s Pedigree
Physical examination showed a normocephalic patient with 
normal facial phenotype. The patient´s height was 110 cm, 
span 92 cm, weight 40 kg, head circumference 57 cm, upper 
segment of 70 cm and lower segment of 40 cm, with an upper/
lower segment ratio of 1.75. Right outer ear dysplasia is evident 
(Figure 2). In the hands, she has clinodactyly, first and second 
phalanx with apparent symphalangism and bilateral thumb 
abduction, showing the so-called “hitchhiker” thumb (Figure 3).
Figure 2. Hypertrophic auricular cartilage, cystic lesions 
that resolve within infant age leaving an ossified pinna.
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Figure 3. Hands with brachydactyly and Ulnar deviation of 
hand,‘hitchhiker’ thumbs.
In the back xyphosis and rotoscoliosis is evident in the 
chest radiography and in the CT (Figures 4-5); in the limbs it 
is remarkable a severe rhizhomelic and moderate mesomelic 
and acromelic shortening (Figure 6). The patient also has 
evidence for mobility restriction of the knees and bilateral 
clubfoot (Figure 7). There are no neurological deficit and her 
IQ and social interaction are normal.
Figure 6. The limbs showed marked micromelic 
shortness.
Figure 4. Patient X ray showed a severe thoracic kyphoscoliosis. 
Figure 5. Magnetic nuclear resonance showed a severe 
thoracic kyphoscoliosis and platyspondyly.
 Figure 7. The limbs showed marked micromelic shortness 
and bilateral clubfeet.
Molecular analysis showed that the patient was compound 
heterozygote for the already reported Arg279Trp substitution 
and an unpublished mutation, a Ser157Thr substitution in 
the SLC26A2 gene. In addition, the patient was homozygous 
for the Thr689Ser polymorphism. The so-called “Finnish 
allele”, a pathological mutation outside the coding sequence, 
was not detected. The father was heterozygous carrier of 
the Arg279Trp substitution, while the mother carried the 
Ser157Thr mutation. 
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Discussion
Diastrophic dysplasia (OMIM # 222600) is a clinical 
syndrome classified within the sulfation disorder group 
in the current “Nosology and Classification of Genetic 
Skeletal Disorders: 2010 Revision” (1). In Latin America, 
its prevalence is 0.13 in 10000 newborns according to data 
from Barbosa et al. taken from ECLAMC (2000-2007) (10), 
while the highest incidence is in Finland, with 1 case per 
30000 newborns. In this paper, we report the first Colombian 
patient with clinical and molecular diagnosisof diastrophic 
dysplasia. 
Patients with diastrophic dysplasia have an increased 
mortality in the neonatal period due to respiratory 
complications resulting from a small chest and a collapsible 
trachea; in adulthood, the disease affects the bone 
structures, tendons, ligaments and joint capsules, causing 
mobility restriction. Frequently, joint contractures and 
spinal deformities worsen with age, leading to the onset 
of scoliosis, lumbar hyperlordosis and thoracolumbar 
kyphosis. 
Our case had several typical features of diastrophic 
dysplasia like calcification of the right ear, hitchhiker thumb 
and orthopedic complications such as shortening of the 
limbs, bilateral clubfoot refractory to surgery and severe 
spinal deformities evidenced by xyphosis and rotoscoliosis. 
The patient did not present respiratory complications in 
childhood or adulthood. Molecular analysis of the SLC26A2 
gene showed that the patient was compound heterozygote 
for the Ser157Thr and Arg279Trp substitutions. 
The Arg279Trp mutation was inherited from her 
father. This mutation causes a substitution of arginine for 
tryptophan at position 279, in a non transmembrane domain 
of the protein, which would allow a residual activity and 
an attenuated phenotype of the disease. This mutation is 
pan-ethnic and it accounts for a thirdof the mutant alleles 
in the Caucasian population (11).
The Ser157Thr substitution, inherited from her mother, 
is a novel mutation that has never been reported. We 
validated its contribution in the development of the disease 
using PolyPhen 2: the software algorithm predicts that the 
mutation is probably deleterious because it is found in a 
conserved region and it is in a transmembrane domain.
There are more than 30 mutations identified in this 
gene, most of these de novo mutations found in families of 
different origins. Based on the literature, 50% are missense, 
33% are deletions, 10% are nonsense mutations, 5% are 
splice site mutations and 3 % are insertions (12). In the case 
of diastrophic dysplasia phenotype, the 5 most common 
mutations are IVS1 +2 T> C, R279W, V340del, C653S and 
R178X (13). 
There have been made numerous correlations between 
mutations in the SLC26A2 gene and the severity of the 
clinical phenotype. DTD patients may be homozygous or 
compound heterozygous for mutations that allow a residual 
activity of the transporter protein. However not all cases show 
this correlation may be because of environmental factors and 
alternative routes in the recruitment of sulfate that may account 
for clinical variability (7). Even if functional studies have 
demonstrated that the Arg279Trp allow a residual function 
of the protein, it is difficult to assess the contribution of 
each mutation to the clinical phenotype of our patient since 
functional studies on the Ser157Thr are not available.
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